Study guide

Typical optic neuritis and ONTT

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Typical optic neuritis and ONTT

Key Takeaways Explain This Topic AI

Typical demyelinating optic neuritis combines a compatible clinical course with exclusion of atypical causes.

ONTT distinguished high-dose treatment from the low-dose oral-only regimen tested in that study.

Visual recovery can be good despite persistent contrast, colour or other deficits, and MRI findings influence neurological assessment.

Last updated: October 2026

Introduction to Demyelinating Optic Neuropathies

Optic neuritis encompasses an inflammatory, demyelinating insult directed against the optic nerve (cranial nerve II). As an evagination of the diencephalon, the optic nerve is an anatomical tract of the central nervous system (CNS). Its axons are myelinated by oligodendrocytes rather than Schwann cells, and it is sheathed by all three meningeal layers (pia, arachnoid, and dura mater) with surrounding cerebrospinal fluid (CSF) in the perioptic subarachnoid space. Demyelinating optic neuritis is the most frequent acute optic neuropathy encountered in young adults, serving as the initial presenting manifestation in approximately 20% of Multiple Sclerosis (MS) patients and occurring during the disease course in up to 50%.

In recent years, the clinical paradigm has shifted from viewing optic neuritis solely as a monosymptomatic manifestation of MS to recognizing distinct pathophysiological autoimmune entities: Multiple Sclerosis-associated Optic Neuritis (MS-ON) , Neuromyelitis Optica Spectrum Disorder (NMOSD) , and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) . Differentiating these conditions at presentation is paramount, as their visual prognoses, neuro-imaging patterns, and therapeutic responses diverge radically.

  • Typical Demyelinating Optic Neuritis
  • Epidemiology & Demographics

Typical demyelinating optic neuritis exhibits a pronounced epidemiological profile:

Age: Predominantly young adults aged 20 to 40 years (peak incidence in the early 30s; uncommon below age 12 or above age 50).

Sex: Strong female preponderance, with a female-to-male ratio of approximately 3:1.

Geography: Higher prevalence in populations of Northern European descent and temperate latitudes, reflecting the epidemiological distribution of Multiple Sclerosis.

Clinical Presentation & Cardinal Signs

The clinical syndrome of typical optic neuritis is characterised by a constellation of five cardinal clinical features:

Subacute, Unilateral Vision Loss: Visual acuity loss is typically acute or subacute, progressing over several hours to days. It characteristically reaches its nadir within 1 to 2 weeks of onset. Visual acuity impairment varies widely: in the landmark Optic Neuritis Treatment Trial (ONTT), approximately 10% presented with 20/20 or better visual acuity, 29% presented with 20/25 to 20/40, 26% with 20/50 to 20/190, and 35% with 20/200 or worse (including light perception).

Orbital Pain Exacerbated by Eye Movements (92%): Present in the vast majority of patients. The discomfort is classically described as a dull, retro-orbital or periorbital ache, which is characteristically aggravated by ocular movements, especially elevation and adduction. Anatomically, this reflects mechanical traction exerted by the origins of the superior and medial rectus muscles directly on the inflamed, sensitized optic nerve sheath at the orbital apex and annulus of Zinn.

Profound Dyschromatopsia (Red Desaturation): Color vision impairment is characteristically out of proportion to the loss of Snellen visual acuity. Patients experience profound desaturation of red hues, which can be rapidly evaluated at the bedside by presenting a bright red object (such as a mydriatic bottle cap) sequentially to each eye. The patient typically describes the target in the affected eye as washed-out, orange, pink, or brownish-gray.

Relative Afferent Pupillary Defect (RAPD / Marcus Gunn Pupil): An RAPD is an indispensable diagnostic finding in unilateral or asymmetrical bilateral disease in the presence of an otherwise normal fellow eye. During the swinging flashlight test, light shifted from the unaffected to the affected eye elicits paradoxical bilateral pupillary dilatation rather than constriction, demonstrating impaired afferent conduction along cranial nerve II.

Visual Field Defects: Although central and centrocaecal scotomas are considered the classic perimetric hallmarks (reflecting preferential inflammation of the papillomacular bundle), the ONTT revealed that virtually any visual field defect can occur. Diffuse generalized depression, three-quadrant depression, arcuate (nerve fibre bundle) scotomas, and altitudinal defects are commonly recorded.

Fundus Appearance: Retrobulbar vs. Papillitis

Ophthalmoscopic evaluation reveals two distinct anatomical presentations:

Retrobulbar Optic Neuritis (Two-Thirds / ~65%): The inflammatory focus is situated posterior to the globe. Slit-lamp biomicroscopy and indirect ophthalmoscopy reveal a completely normal optic disc, crisp margins, and normal retinal vasculature. This gives rise to the classic clinical aphorism: "The doctor sees nothing, and the patient sees nothing."

Anterior Papillitis (One-Third / ~35%): The inflammatory process involves the optic nerve head. Fundus examination reveals mild-to-moderate optic disc hyperaemia, oedematous blurred disc margins, distension of peripapillary retinal venules, and occasional peripapillary splinter haemorrhages. Vitreous cells are typically absent or exceedingly sparse; prominent vitritis or macular exudative star formation should prompt immediate consideration of alternative diagnoses (such as neuroretinitis, cat-scratch disease, or sarcoidosis).

Landmark Findings of the Optic Neuritis Treatment Trial (ONTT)

The Optic Neuritis Treatment Trial (ONTT), initiated in 1988 under the leadership of Roy Beck, is the definitive multicentre randomised trial that established modern management protocols and long-term prognostic understanding of demyelinating optic neuritis.

Study Design & Treatment Arms

The ONTT enrolled 457 patients aged 18 to 46 years presenting within 8 days of acute unilateral optic neuritis. Patients were randomised to one of three treatment regimens:

Oral Prednisone Arm: Oral prednisone alone at standard doses (1 mg/kg/day) for 14 days, followed by a 4-day taper.

Intravenous Methylprednisolone Arm: High-dose IV methylprednisolone (250 mg every 6 hours / 1,000 mg daily) for 3 days, followed by oral prednisone (1 mg/kg/day) for 11 days, followed by a 4-day taper.

Oral Placebo Arm: Inactive placebo tablets matching the oral prednisone schedule.

The Three Core Findings of the ONTT

Oral Prednisone Alone is Contraindicated: Oral prednisone administered in standard dosages (1 mg/kg/day) without preceding high-dose intravenous therapy did not improve the rate or degree of visual recovery compared to placebo. Critically, it doubled the rate of recurrent optic neuritis at 2 years (30% recurrence rate in the oral prednisone cohort vs. 16% in the placebo group and 13% in the IV group). Consequently, standard-dose oral prednisone alone is strictly contraindicated in acute typical optic neuritis.

High-Dose IV Corticosteroids Accelerate Recovery Speed Only: Intravenous methylprednisolone followed by oral prednisone accelerated the speed of visual recovery, allowing patients to regain visual acuity and contrast sensitivity several weeks faster than the placebo group. However, by 6 to 12 months, and maintained throughout the 5-, 10-, and 15-year follow-up intervals, there was no statistically significant difference in final visual acuity, visual field sensitivity, or contrast sensitivity between the IV steroid and placebo arms. High-dose IV methylprednisolone acts to hasten recovery, but does not alter long-term structural or visual outcomes.

Brain MRI is the Single Most Powerful Predictor of Multiple Sclerosis: Baseline brain magnetic resonance imaging (MRI) with gadolinium enhancement is the most vital prognostic investigation. The ONTT demonstrated that the 15-year cumulative risk of developing clinically definite Multiple Sclerosis (CDMS) is strictly stratified by the presence and quantity of baseline demyelinating white matter lesions:

0 Lesions on Baseline Brain MRI: 15-year risk of developing MS is 25% .

≥ 1 \ge 1 ≥ 1 Lesion on Baseline Brain MRI: 15-year risk of developing MS rises to 72% .

Important

Typical demyelinating white matter lesions on brain MRI are defined as ovoid, hyperintense areas on T2-weighted and FLAIR sequences measuring ≥ 3 mm \ge 3\text{ mm} ≥ 3 mm in diameter, located in the periventricular, juxtacortical, or infratentorial regions. Periventricular lesions oriented perpendicularly along medullary venules are termed Dawson's fingers .

Visual Recovery & Subclinical Residual Phenomena

The natural history of typical demyelinating optic neuritis is overwhelmingly favourable. Over 90% of patients achieve visual acuity of 20/40 or better within 6 to 12 months, and over 70% regain 20/20 or better. However, fine functional deficits frequently persist indefinitely due to subclinical axonal loss and persistent myelin thinning:

Contrast Sensitivity & Stereoacuity Deficits: Many patients continue to complain of subjective "dimness" or reduced image quality despite 20/20 Snellen acuity.

Delayed Visual Evoked Potentials (VEP): Prolongation of the P100 latency persists permanently on pattern VEP, demonstrating chronic conduction delay along remyelinated axons.

Uhthoff's Phenomenon: Transient, reversible deterioration of vision (or other neurological functions) precipitated by an elevation in core body temperature (e.g., following physical exercise, taking a hot bath, or experiencing a febrile illness). Elevated temperature diminishes the safety factor of action potential propagation across chronically demyelinated axonal segments.

Pulfrich Phenomenon: An altered stereo-perception of motion in depth resulting from asymmetrical inter-ocular conduction velocities. A pendulum swinging perpendicularly across the visual field appears to the patient to move in an elliptical path, which can cause depth-perception disorientation when driving or catching moving objects.